Natsuo Tachikawa
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Characterization of the Proinflammatory Cytokine Profile during Acute SARS-CoV-2 Infection in People with Human Immunodeficiency Virus.
Journal: Japanese journal of infectious diseases
Published: June 30, 2024
Safety and efficacy of 5-aminolevulinic acid phosphate/iron in mild-to-moderate coronavirus disease 2019: A randomized exploratory phase II trial.
Journal: Medicine
Published: September 01, 2023
Earliest histopathological changes in COVID-19 pneumonia with comprehensive gene expression analyses: A case series study.
Journal: Histology and histopathology
Published: December 01, 2022
Multimodal single-cell analyses of peripheral blood mononuclear cells of COVID-19 patients in Japan.
Multimodal single-cell analyses of peripheral blood mononuclear cells of COVID-19 patients in Japan.
Journal: Scientific reports
Published: September 06, 2022
Intradermal Hepatitis B Vaccination in Non-responder People Living with Human Immunodeficiency Virus in Japan.
Journal: Japanese journal of infectious diseases
Published: May 01, 2022
An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 06, 2022
High titer of antibody against the SARS-CoV-2 spike protein among patients receiving neutralizing antibody cocktail therapy with REGN-COV.
Journal: Infection
Published: December 24, 2021
DOCK2 is involved in the host genetics and biology of severe COVID-19.
Journal: Nature
Published: October 26, 2021
Acute pancreatitis or severe increase in pancreatic enzyme levels following remdesivir administration in COVID-19 patients: an observational study.
Journal: Scientific reports
Published: September 23, 2021
Author Correction: The U‑shaped association of serum iron level with disease severity in adult hospitalized patients with COVID‑19.
Journal: Scientific reports
Published: August 17, 2021
Recovery from severe persistent COVID-19 without evidence of an anti-SARS-CoV-2 antibody response in a man with mantle cell lymphoma treated with rituximab.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: June 21, 2021
Last Updated: 09/26/2026